Bernard J. Zovighian, CEO at Edwards Lifesciences Corp (EW), sold 13,627 shares at $69.51 ($857K) on 2025-03-10, disclosed to the SEC on 2025-03-10.
Scheduled sale ($857k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,299 | $0 | 0.0% |
| 2 | $69.51 | 6,164 | $428K | 50.0% |
| 3 | $69.51 | 6,164 | $428K | 50.0% |
| Total | $62.88 avg | 13,627 | $857K | 100% |
| Filing → |
| EW | SELL | 2026-05-12 | $2.8M | — | Filing → |
| EW | SELL | 2026-02-13 | $3.4M | — | Filing → |
| EW | SELL | 2025-12-10 | $4.3M | — | Filing → |